Zurich Cantonal Bank
SWTX

Zurich Cantonal Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Zurich Cantonal Bank’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,919
Closed -$560K – 2601
2025
Q2 		$560K Buy
11,919
+1,606
+16% +$71.4K ﹤0.01% 1584
2025
Q1 		$455K Sell
10,313
-1,372
-12% -$63.2K ﹤0.01% 1653
2024
Q4 		$422K Buy
11,685
+2,561
+28% +$89.5K ﹤0.01% 1731
2024
Q3 		$292K Hold
9,124
– – ﹤0.01% 1893
2024
Q2 		$344K Sell
9,124
-15
-0.2% -$631 ﹤0.01% 1752
2024
Q1 		$450K Buy
9,139
+494
+6% +$22.8K ﹤0.01% 1539
2023
Q4 		$316K Buy
8,645
+2,387
+38% +$62.3K ﹤0.01% 1812
2023
Q3 		$145K Hold
6,258
– – ﹤0.01% 2167
2023
Q2 		$164K Hold
6,258
– – ﹤0.01% 2053
2023
Q1 		$161K Hold
6,258
– – ﹤0.01% 2016
2022
Q4 		$163K Buy
6,258
+1,778
+40% +$43.8K ﹤0.01% 1949
2022
Q3 		$128K Buy
+4,480
New +$128K ﹤0.01% 2037
2022
Q1 		– Sell
-801
Closed -$50K – 2837
2021
Q4 		$50K Sell
801
-62
-7% -$4.1K ﹤0.01% 2739
2021
Q3 		$55K Buy
863
+8
+0.9% +$616 ﹤0.01% 2588
2021
Q2 		$70K Buy
855
+40
+5% +$3.04K ﹤0.01% 2359
2021
Q1 		$60K Buy
+815
New +$63.8K ﹤0.01% 2340

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Zurich Cantonal Bank's SWTX Position: Q3 2025 in Review

Zurich Cantonal Bank sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 11,919 shares — an estimated $560K sold.

Zurich Cantonal Bank first reported a position in SWTX in Q1 2021 and held it in 16 quarters. The position peaked at $560K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Zurich Cantonal Bank reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 11,919 SpringWorks Therapeutics shares in Q3 2025, an estimated $560K.
  • Zurich Cantonal Bank first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 16 quarters.
  • Zurich Cantonal Bank's SpringWorks Therapeutics position peaked at $560K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Zurich Cantonal Bank's 13F filing for Q3 2025, filed 14 Nov 2025.